ea0063p284 | Pituitary and Neuroendocrinology 1 | ECE2019
Pronin Vyacheslav
, Zherebchikova Kristina
, Malysheva Alena
, Kozhevnikov Alexander
, Kalinin Pavel
, Astafina Lyudmila
, Rotin Daniil
, Vorontsov Alexander
, Ambrosimov Alexander
, Grigoriev Andrei
, Shishkina Lyudmila
, Pronin Eugeny
, Azizyan Vilen
, Godkov Ivan
, Belysheva Elena
, Demidova Tatiana
, Poteshkin Yury
Introduction: A growth hormone-secreting pituitary adenoma (GH-PA) increases the risk of complications and death. ItÂ’s management is determined by MRI data and decrease of insulin-like growth factor-1 (IGF-1) during the octreotide suppression test (OST). Currently, there is evidence that MRI-T2-hypointensive somatotropinoma and high expression of somatostatin receptors type 2 (SSTR2) according to immunohistochemical analysis (IHC) predict high efficacy of somatostatin ana...